The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression.

Our study suggests that PRMT5 and LSD1 function as a dual epigenetic modifier to promote Slug induced EMT program, suggesting that the inhibition of PRMT5 and LSD1 presents a potential therapeutic strategy against cancer metastasis.